Standard Analyte Generator
    4.
    发明申请

    公开(公告)号:US20160258910A1

    公开(公告)日:2016-09-08

    申请号:US14638544

    申请日:2015-03-04

    Abstract: The invention describes the process by which a standard mixture of organic compounds are spiked and retained onto a composite sorbent matrix for the controlled generation of a standard in fluid above the spiked matrix either in gas (headspace) or aqueous phase which is contained in portable vials. The novelty of the aforementioned composite matrix stems from the combination of an immobilizing liquid phase such as silicone oil or a polyacrylonitrile solution, and solid, porous particles such as polystyrene-co-divinylbenzene (PS-DVB) or Hydrophilic/Lipophilic Balance (HLB) particles to strongly retain the spiked standards facilitating high capacity which translates into prolonged use as a source of calibrant. These novel composite mixtures exhibit sorptive capabilities greater than the sum of their individual components producing a standard analyte generator far superior to those described in the prior art. In addition swelling of the particles with the liquid phase facilitates immobilization of the composite sorbent matrix in the vial. Immobilization of said particles has also been achieved by cross-linking of a liquid polymeric solution such as polydimethylsiloxane (PDMS), allowing the composite sorbent matrix to be uniformly distributed on the vessel wall. With thermodynamic equilibrium strongly favoring the sorbent phase for a wide range of chemical compounds, this invention allows for the reproducible generation of an ultra-low concentration standard analyte mixture in fluid. If the fluid is gaseous, extractions from this headspace can be performed via solid phase microextraction (SPME), needle trap devices (NTD), or direct headspace extraction for injection onto various hyphenated gas chromatography (GC) systems. If the fluid is aqueous, extractions may be performed directly from the standard water for injection onto hyphenated GC or liquid chromatography (LC) systems. The invention can be used for a variety of applications ranging from integrated GC-MS or LC-MS tuning, automated instrument quality control (QC), preparation of reusable external calibration mixtures and, addition of internal standards wherein the method provides long-term stability, inter-batch reproducibility, repeatable analyte loading of the fluid, and quantifiable low concentrations at given temperatures.

    IMMUNOSORBENT AND IMMUNOAFFINITY COLUMN FOR AFLATOXIN M1 NANOBODY AND PREPARATION METHOD THEREOF
    5.
    发明申请
    IMMUNOSORBENT AND IMMUNOAFFINITY COLUMN FOR AFLATOXIN M1 NANOBODY AND PREPARATION METHOD THEREOF 有权
    AFLATOXIN M1 NANOBODY的免疫球蛋白和免疫球蛋白及其制备方法

    公开(公告)号:US20150276729A1

    公开(公告)日:2015-10-01

    申请号:US14667378

    申请日:2015-03-24

    CPC classification number: G01N30/48 G01N33/54346 G01N2030/486

    Abstract: An aflatoxin M1 nanobody, an immunosorbent and an immunoaffinity column. The aflatoxin M1 nanobody 2014AFM-G2 has the amino acid sequence of SEQ ID NO:7, is encoded by the nucleic acid sequence of SEQ IDNO:8, has a 50% inhibiting concentration IC50 to aflatoxin M1 of 0.208 ng/mL, and has cross reaction rates with aflatoxins B1, B2, G1, and G2 of 9.43%, 5.93%, 4.87% and 6.17%, respectively. The immunosorbent includes a solid phase carrier and aflatoxin M1 nanobody 2014AFM-G2 coupled with the solid phase carrier. The immunoaffinity column is loaded with the aflatoxin M1 nanobody immunosorbent. It can be used for purifying and concentrating an extracting solution of a sample before loading to a machine for detection and the immunoaffinity column can be used repeatedly for many times.

    Abstract translation: 黄曲霉毒素M1纳米体,免疫吸附剂和免疫亲和柱。 黄曲霉毒素M1纳米粒子2014AFM-G2具有SEQ ID NO:7的氨基酸序列,由SEQ ID NO:8的核酸序列编码,对黄曲霉毒素M1的IC50值为0.208ng / mL,具有50%的抑制浓度,具有 黄曲霉毒素B1,B2,G1和G2的交叉反应率分别为9.43%,5.93%,4.87%和6.17%。 免疫吸附剂包括与固相载体偶联的固相载体和黄曲霉毒素M1纳米颗粒。 免疫亲和柱装载有黄曲霉毒素M1纳米体免疫吸附剂。 它可以用于在加载到机器进行检测之前将样品的提取溶液进行纯化和浓缩,并且免疫亲和柱可以重复使用多次。

    METHOD FOR MEASURING HEMOGLOBINS
    7.
    发明申请
    METHOD FOR MEASURING HEMOGLOBINS 审中-公开
    测量血红蛋白的方法

    公开(公告)号:US20140162369A1

    公开(公告)日:2014-06-12

    申请号:US14130112

    申请日:2012-01-11

    Applicant: Kazuyuki Oishi

    Inventor: Kazuyuki Oishi

    Abstract: The present invention aims to provide a method of measuring hemoglobins which can measure hemoglobins in a short time at high accuracy. The present invention also aims to provide a method of measuring hemoglobin A1c, a method of simultaneously measuring hemoglobin A1c and hemoglobin F, a method of simultaneously measuring hemoglobin A1c and hemoglobin A2, and a method of simultaneously measuring hemoglobin A1c and abnormal hemoglobins, each utilizing the above-mentioned method of measuring hemoglobins by liquid chromatography. The present invention relates to a method of measuring hemoglobins by liquid chromatography. A column used in the method is filled with, as a column-packing material, cation-exchangeable particles including cross-linked polymer particles having a cation-exchange-group-containing polymer bonded to the surface of the cross-linked polymer particles, and the column shows a pressure value of 9.8×103 Pa or higher and 29.4×105 Pa or lower when an eluent for measurement is delivered at 1.0 mL/min.

    Abstract translation: 本发明的目的在于提供一种能够高精度地测定短时间内的血红蛋白的血红蛋白的测定方法。 本发明的目的还在于提供一种测定血红蛋白A1c的方法,同时测定血红蛋白A1c和血红蛋白F的方法,同时测定血红蛋白A1c和血红蛋白A2的方法,以及同时测定血红蛋白A1c和异常血红蛋白的方法, 上述通过液相色谱法测定血红蛋白的方法。 本发明涉及通过液相色谱法测定血红蛋白的方法。 在该方法中使用的柱子作为柱状填充材料填充有可交联聚合物颗粒的阳离子交换颗粒,所述交联聚合物颗粒具有结合到交联聚合物颗粒表面的含阳离子交换基团的聚合物,以及 当以1.0mL / min的速度递送测量用洗脱液时,该柱的压力值为9.8×10 3 Pa以上,29.4×10 5 Pa以下。

Patent Agency Ranking